|
1
|
Smith SH, Goldschmidt MH and McManus PM: A
comparative review of melanocytic neoplasms. Vet Pathol.
39:651–678. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bergman PJ: Canine oral melanoma. Clin
Tech Small Anim Pract. 22:55–60. 2007. View Article : Google Scholar
|
|
3
|
Bateman KE, Catton PA, Pennock PW and
Kruth SA: 0-7-21 radiation therapy for the treatment of canine oral
melanoma. J Vet Intern Med. 8:267–272. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Blackwood L and Dobson JM: Radiotherapy of
oral malignant melanomas in dogs. J Am Vet Med Assoc. 209:98–102.
1996.PubMed/NCBI
|
|
5
|
Proulx DR, Ruslander DM, Dodge RK, Hauck
ML, Williams LE, Horn B, Price GS and Thrall DE: A retrospective
analysis of 140 dogs with oral melanoma treated with external beam
radiation. Vet Radiol Ultrasound. 44:352–359. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rassnick KM, Ruslander DM, Cotter SM,
Al-Sarraf R, Bruyette DS, Gamblin RM, Meleo KA and Moore AS: Use of
carboplatin for treatment of dogs with malignant melanoma: 27 cases
(1989–2000). J Am Vet Med Assoc. 218:1444–1448. 1996.PubMed/NCBI
|
|
7
|
Murphy S, Hayes AM, Blackwood L, Maglennon
G, Pattinson H and Sparkes AH: Oral malignant melanoma - the effect
of coarse fractionation radiotherapy alone or with adjuvant
carboplatin therapy. Vet Comp Oncol. 3:222–229. 2005. View Article : Google Scholar
|
|
8
|
Dank G, Rassnick KM, Sokolovsky Y, Garrett
LD, Post GS, Kitchell BE, Sellon RK, Kleiter M, Northrup N and
Segev G: Use of adjuvant carboplatin for treatment of dogs with
oral malignant melanoma following surgical excision. Vet Comp
Oncol. 12:78–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Freeman KP, Hahn KA, Harris FD and King
GK: Treatment of dogs with oral melanoma by hypofractionated
radiation therapy and platinum-based chemotherapy (1987–1997). J
Vet Intern Med. 17:96–101. 2003.PubMed/NCBI
|
|
10
|
Saleem M, Kaur S, Kweon MH, Adhami VM,
Afaq F and Mukhtar H: Lupeol, a fruit and vegetable based
triterpene, induces apoptotic death of human pancreatic
adenocarcinoma cells via inhibition of Ras signaling pathway.
Carcinogenesis. 26:1956–1964. 2005. View Article : Google Scholar
|
|
11
|
Chaturvedi PK, Bhui K and Shukla Y:
Lupeol: connotations for chemoprevention. Cancer Lett. 263:1–13.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saleem M: Lupeol, a novel
anti-inflammatory and anti-cancer dietary triterpene. Cancer Lett.
285:109–115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saleem M, Maddodi N, Abu Zaid M, Khan N,
bin Hafeez B, Asim M, Suh Y, Yun JM, Setaluri V and Mukhtar H:
Lupeol inhibits growth of highly aggressive human metastatic
melanoma cells in vitro and in vivo by inducing apoptosis. Clin
Cancer Res. 14:2119–2127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nitta M, Azuma K, Hata K, Takahashi S,
Ogiwara K, Tsuka T, Imagawa T, Yokoe I, Osaki T, Minami S and
Okamoto Y: Systemic and local injections of lupeol inhibit tumor
growth in a melanoma-bearing mouse model. Biomed Rep. 1:641–645.
2013.PubMed/NCBI
|
|
15
|
Hata K, Hori K, Mukaiyama T, Sakamoto K
and Takahashi S: Activators of melanin biosynthesis from Lactuca
indica. Nat Med. 57:238–241. 2003.
|
|
16
|
Radzi R, Osaki T, Tsuka T, Imagawa T,
Minami S, Nakayama Y and Okamoto Y: Photodynamic hyperthermal
therapy with indocyanine green (ICG) induces apoptosis and cell
cycle arrest in B16F10 murine melanoma cells. J Vet Med Sci.
74:545–551. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Radzi R, Osaki T, Tsuka T, Imagawa T,
Minami S and Okamoto Y: Morphological study in B16F10 murine
melanoma cells after photodynamic hyperthermal therapy with
indocyanine green (ICG). J Vet Med Sci. 74:465–472. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Onoyama M, Tsuka T, Imagawa T, Osaki T,
Minami S, Azuma K, Kawashima K, Ishi H, Takayama T, Ogawa N and
Okamoto Y: Photodynamic hyperthermal chemotherapy with indocyanine
green: a novel cancer therapy for 16 cases of malignant soft tissue
sarcoma. J Vet Sci. 15:117–123. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Onoyama M, Azuma K, Tsuka T, Imagawa T,
Osaki T, Minami S, Ogawa N and Okamoto Y: Effects of photodynamic
hyperthermal therapy with indocyanine green on tumor growth in a
colon 26 tumor-bearing mouse model. Oncol Lett. 7:1147–1150.
2014.PubMed/NCBI
|
|
20
|
MacEwen EG, Patnaik AK, Harvey HJ, et al:
Canine oral melanoma: comparison of surgery versus surgery plus
Corynebacterium parvum. Cancer Invest. 4:397–402. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Theon AP, Rodriguez C and Madewell BR:
Analysis of prognostic factors and patterns of failure in dogs with
malignant oral tumors treated with megavoltage irradiation. J Am
Vet Med Assoc. 210:778–784. 1997.PubMed/NCBI
|
|
22
|
Boria PA, Murry DJ, Bennett PF, Glickman
NW, Snyder PW, Merke BL, Schlittler DL, Mutsaers AJ, Thomas RM and
Knapp DW: Evaluation of cisplatin combined with piroxicam for the
treatment of oral malignant melanoma and oral squamous cell
carcinoma in dogs. J Am Vet Med Assoc. 224:388–394. 2004.
View Article : Google Scholar : PubMed/NCBI
|
